© 2009 Molecular Vision

Purpose Primary congenital glaucoma (PCG) is an autosomal recessive eye disorder that is postulated to result from developmental defects in the anterior eye segment. Mutations in the cytochrome P4501B1 (CYP1B1) gene are a predominant cause of congenital glaucoma. In this study we identify CYP1B1 mutations in PCG patients. Methods Twenty-three unrelated PCG patients and 50 healthy controls were enrolled in the study. CYP1B1 was screened for mutations by PCR and DNA sequencing. Results DNA sequencing revealed a total of 15 mutations. Out of these, four (p.I94X, p.H279D, p.Q340H, and p.K433K) were novel mutations and five were known pathogenic mutations. Five coding single nucleotide polymorphisms and one intronic single nucleotide polymorphism (rs2617266) were also found. Truncating mutations (p.I94X and p.R355X) were associated with the most severe disease phenotype. It is possible that patients with two null alleles with no catalytic activity may present with a more severe phenotype of the disease compared to patients with one null allele (heterozygous). The disease phenotype of patients with CYP1B1 mutations was more severe compared with the clinical phenotype of patients negative for CYP1B1 mutations. Conclusion Mutations in CYP1B1 are a major cause for PCG in our patients. Identifying mutations in subjects at risk of developing glaucoma, particularly among relatives of PCG patients, is of clinical significance. These developments may help in reducing the disease frequency in familial cases. Such studies will be of benefit in the identification of pathogenic mutations in different populations and will enable us to develop simple and rapid diagnostic tests for analyzing such cases.

[1]  V. P. Costa,et al.  CYP1B1 Gene Analysis in Primary Congenital Glaucoma Brazilian Patients: Novel Mutations and Association With Poor Prognosis , 2010, Journal of glaucoma.

[2]  A. Ganesh,et al.  Molecular analysis of CYP1B1 in Omani patients with primary congenital glaucoma: a pilot study , 2009, Molecular vision.

[3]  R. Dada,et al.  Mutation spectrum of CYP1B1 in North Indian congenital glaucoma patients , 2009, Molecular vision.

[4]  Carmen Ayuso,et al.  CYP1B1 mutations in Spanish patients with primary congenital glaucoma: phenotypic and functional variability , 2009, Molecular vision.

[5]  J. Schenkman,et al.  Characterization of the biochemical and structural phenotypes of four CYP1B1 mutations observed in individuals with primary congenital glaucoma , 2008, Pharmacogenetics and genomics.

[6]  R. Purohit,et al.  A novel computational and structural analysis of nsSNPs in CFTR gene , 2008, Genomic Medicine.

[7]  P. Grant,et al.  The characterisation and functional analysis of the human glyoxalase-1 gene using methods of bioinformatics. , 2004, Gene.

[8]  H. Garchon,et al.  CYP1B1 mutations in French patients with early-onset primary open-angle glaucoma , 2004, Journal of Medical Genetics.

[9]  S. Hasnain,et al.  Correlations of genotype with phenotype in Indian patients with primary congenital glaucoma. , 2004, Investigative ophthalmology & visual science.

[10]  R. Lewis,et al.  Cytochrome P4501B1 mutations cause only part of primary congenital glaucoma in Ecuador , 2004, Ophthalmic genetics.

[11]  H. Garchon,et al.  Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France , 2003, Human mutation.

[12]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[13]  M. Araie,et al.  Phenotype of cytochrome P4501B1 gene (CYP1B1) mutations in Japanese patients with primary congenital glaucoma , 2003, The British journal of ophthalmology.

[14]  P. Bork,et al.  Human non-synonymous SNPs: server and survey. , 2002, Nucleic acids research.

[15]  V. P. Costa,et al.  Molecular genetics of primary congenital glaucoma in Brazil. , 2002, Investigative ophthalmology & visual science.

[16]  N. Ahmed,et al.  Identification of novel mutations causing familial primary congenital glaucoma in Indian pedigrees. , 2002, Investigative ophthalmology & visual science.

[17]  I. Kimura,et al.  Novel cytochrome P4501B1 (CYP1B1) gene mutations in Japanese patients with primary congenital glaucoma. , 2001, Investigative ophthalmology & visual science.

[18]  C. Mardin,et al.  Primary Congenital Glaucoma: Three Case Reports on Novel Mutations and Combinations of Mutations in the GLC3A (CYP1B1) Gene , 2001, Journal of glaucoma.

[19]  Warren C. Lathe,et al.  Prediction of deleterious human alleles. , 2001, Human molecular genetics.

[20]  P. Bork,et al.  Towards a structural basis of human non-synonymous single nucleotide polymorphisms. , 2000, Trends in genetics : TIG.

[21]  J. Lupski,et al.  Multiple CYP1B1 mutations and incomplete penetrance in an inbred population segregating primary congenital glaucoma suggest frequent de novo events and a dominant modifier locus. , 2000, Human molecular genetics.

[22]  V. Ferák,et al.  Identification of a single ancestral CYP1B1 mutation in Slovak Gypsies (Roms) affected with primary congenital glaucoma , 1999, Journal of medical genetics.

[23]  L Dandona,et al.  Population-based assessment of childhood blindness in southern India. , 1998, Archives of ophthalmology.

[24]  A. Child,et al.  Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1. , 1998, American journal of human genetics.

[25]  J. Lupski,et al.  Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia. , 1998, American journal of human genetics.

[26]  M. Sarfarazi,et al.  Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. , 1997, Human molecular genetics.

[27]  M. Sarfarazi,et al.  A second locus (GLC3B) for primary congenital glaucoma (Buphthalmos) maps to the 1p36 region. , 1996, Human molecular genetics.

[28]  M. Sarfarazi,et al.  Assignment of a locus (GLC3A) for primary congenital glaucoma (Buphthalmos) to 2p21 and evidence for genetic heterogeneity. , 1995, Genomics.

[29]  E. Jabs,et al.  Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. , 1994, The Journal of biological chemistry.

[30]  H. Yamazaki,et al.  Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. , 1992, Carcinogenesis.

[31]  D W Nebert,et al.  Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions. , 1991, Molecular endocrinology.

[32]  V. P. deLuise,et al.  Primary infantile glaucoma (congenital glaucoma). , 1983, Survey of ophthalmology.

[33]  K. Kaur,et al.  The transcription factor gene FOXC1 exhibits a limited role in primary congenital glaucoma. , 2009, Investigative ophthalmology & visual science.

[34]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[35]  I. Kimura,et al.  Novel Cytochrome P 4501 B 1 ( CYP 1 B 1 ) Gene Mutations in Japanese Patients with Primary Congenital Glaucoma , 2001 .

[36]  G. Eichele,et al.  Retinoid metabolizing enzymes in development , 1999, BioFactors.

[37]  J. François.  Congenital glaucoma and its inheritance. , 1980, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.